BIA
ALAB icon

Benchmark Investment Advisors’s Astera Labs ALAB Stock Holding History

Benchmark Investment Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,019
Closed -$331K – 77
2026
Q1 		$331K Buy
+3,019
New +$430K 0.19% 65
2025
Q3 		$345K Buy
+1,762
New +$290K 0.2% 64

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Benchmark Investment Advisors's ALAB Position: Q2 2026 in Review

Benchmark Investment Advisors sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 3,019 shares — an estimated $331K sold.

Benchmark Investment Advisors first reported a position in ALAB in Q3 2025 and held it in 2 quarters. The position peaked at $345K in Q3 2025. 990 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Benchmark Investment Advisors reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • Benchmark Investment Advisors sold 3,019 Astera Labs shares in Q2 2026, an estimated $331K.
  • Benchmark Investment Advisors first reported a position in Astera Labs in Q3 2025 and held it in 2 quarters.
  • Benchmark Investment Advisors's Astera Labs position peaked at $345K in Q3 2025.
  • 990 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Benchmark Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.